Cargando…
Amphipathic Peptide Antibiotics with Potent Activity against Multidrug-Resistant Pathogens
The emergence and prevalence of multidrug-resistant (MDR) bacteria have posed a serious threat to public health. Of particular concern are methicillin-resistant Staphylococcus aureus (MRSA) and bla(NDM), mcr-1 and tet(X)-positive Gram-negative pathogens. The fact that few new antibiotics have been a...
Autores principales: | Shi, Jingru, Chen, Chen, Wang, Dejuan, Tong, Ziwen, Wang, Zhiqiang, Liu, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063935/ https://www.ncbi.nlm.nih.gov/pubmed/33804947 http://dx.doi.org/10.3390/pharmaceutics13040438 |
Ejemplares similares
-
Potent Broad-Spectrum Antibacterial Activity of Amphiphilic Peptides against Multidrug-Resistant Bacteria
por: Liu, Yuan, et al.
Publicado: (2020) -
Reversion of antibiotic resistance in multidrug-resistant pathogens using non-antibiotic pharmaceutical benzydamine
por: Liu, Yuan, et al.
Publicado: (2021) -
The antimicrobial peptide LI14 combats multidrug-resistant bacterial infections
por: Shi, Jingru, et al.
Publicado: (2022) -
Truncated Pleurocidin Derivative with High Pepsin Hydrolysis Resistance to Combat Multidrug-Resistant Pathogens
por: Wang, Dejuan, et al.
Publicado: (2022) -
An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria
por: Elliott, Alysha G., et al.
Publicado: (2020)